"March 5, 2013 -- Spring allergy season is again off to an early start in many parts of the country, and doctors say there are some signs it may be even more miserable than usual this year.
Last year was the fourth warmest winter on re"...
- Patient Information:
Details with Side Effects
LASTACAFT™ (alcaftadine ophthalmic solution) is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis.
Dosage Forms And Strengths
Topical ophthalmic solution containing alcaftadine, 0.25% (2.5 mg/mL).
Storage And Handling
LASTACAFT™ (alcaftadine ophthalmic solution) 0.25% is supplied in an opaque, white low-density polyethylene bottle with a white polypropylene cap.
3 mL fill in 5 mL bottle (NDC 68669-41203)
Storage: Store at 15-25°C (59-77°F)
Manufactured for Vistakon Pharmaceuticals, LLC., Jacksonville, FL 32256 USA
Last reviewed on RxList: 8/20/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Lastacaft Information
Lastacaft - User Reviews
Lastacaft User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.